Patient Advisory Board
Stakeholders, including regulators and policymakers, are increasingly focusing on patient-centered care and outcomes that matter to patients, e.g.: OECD, European Medicines Agency.
Based on our strategic plan, we established a Patient Advisory Board (PAB). Therefor, we would like to include one male and one female young adult per SWEET hub between 18 and 21 years. If you know someone who is suitable and may be interested, please contact us via e-mail (sweet-project@hka.de).
We are welcoming the first Patient Advisory Board members to our SWEET network and thank you very much for your helpful willingness to support our project. As we want to set a strong focus on the patients’ view and needs, to us it is very important and will be immensely helpful to have representatives on board.
The first projects of our Patient Advisory Board members will be the involvement in the SWEET PRO-Study.
